Thoracic outlet syndrome (TOS) encompasses a trio of conditions that result from compression of the neurovascular structures that serve the upper extremity: the brachial plexus (neurogenic TOS), the subclavian vein (venous TOS), and the subclavian artery (arterial TOS), and each syndrome is defined by a distinct presentation. This article will address neurogenic thoracic outlet syndrome, the most prevalent and the most controversial form of TOS, and will highlight opportunities for innovation in this field.
Neurogenic TOS is a commonly debilitating condition caused by dynamic compression of the brachial plexus in its traverse between the first rib and scalene muscles, resulting in pain and paresthesias of the upper extremity. Neurogenic TOS is by far the most common type of TOS, with more than 90% of all TOS cases in large, single-institution series accounted for by neurogenic TOS. 1, 2 Within a more recent multi-institutional national sample through the American College of Surgeons National Surgical Quality Improvement Program database of 1431 patients undergoing first or cervical rib resection for TOS, 83% of TOS procedures were performed for neurogenic TOS. 3 The initial treatment of neurogenic TOS nearly always begins with nonsurgical therapy, considered the standard of care for most cases. It is not uncommon, however, to encounter patients who do not tolerate physical therapy. Nonoperative management of neurogenic TOS includes TOS-specific physical therapy, ergonomic modifications, and pain management. Surgery is offered when symptoms become disabling, and its objective is liberation of the brachial plexus from external compression. It is critical here to recognize the existence of neurogenic pectoralis minor syndrome, which has a similar presentation to neurogenic TOS. In neurogenic pectoralis minor syndrome, the anatomic site of brachial plexus compression is the retropectoral space. Pectoralis minor tenotomy is an effective treatment for this condition and can be performed as a low-risk outpatient procedure. 4 On the basis of physical examination findings and response to lidocaine muscle blocks, neurogenic TOS can be differentiated from neurogenic pectoralis minor syndrome, although some patients will have compression at both sites (''double crush syndrome''). This article will focus on the more prevalent neurogenic TOS, for which resection of the first rib, with either scalenectomy or scalenotomy, is the surgical procedure best suited to decompress the thoracic outlet.
DIAGNOSIS
Controversy surrounding the field of neurogenic TOS surgery is fueled by variability in both its diagnosis and management, as well as by its poorly understood pathophysiology. Neurogenic TOS is a clinical diagnosis that often presents with nonspecific symptoms that overlap with other clinical disorders, and it is only rarely associated with objective findings. Electromyographic results suggestive of neurogenic TOS or hand atrophy are found only in about 1% of those with the syndrome, and a cervical rib is present in only 5% to 9% of cases of neurogenic TOS. 5, 6 The frequent diagnostic uncertainty in diagnosis is reflected in a now-retired nomenclature system for neurogenic TOS that incorporated ''disputed TOS'' as a clinical entity. 7 Because of the longstanding absence of well-defined and consistently applied diagnostic criteria for neurogenic TOS, the Society of Vascular Surgery published reporting standards for neurogenic TOS in September 2016. 7 In this document, diagnostic criteria for neurogenic TOS are proposed to include 3 of the 4 following criteria: Although it may not be immediately evident, these proposed diagnostic criteria represent a major advance in the field of neurogenic TOS. Such standardization of diagnostic criteria will improve identification of patients with this disorder and result in use of consistent terms among caregivers, and therefore ultimately has promise to improve patient outcomes. Validation studies will be required and are anticipated to correlate response to treatment with accuracy of the diagnosis made with the proposed criteria.
OUTCOMES REPORTING
The neurogenic TOS surgical literature is composed almost entirely of retrospective studies, and analyses of symptom improvement are based almost exclusively on subjective measures. Beginning in the 1960s, the first approximately 4 decades of neurogenic TOS publications reported surgical outcomes that used clinical assessment systems with results derived from surgeon and / or patient interpretations of surgical outcome, such as ''excellent, good, fair, or poor'' or ''success, recurrence, or failure.'' Overall, mostly ''excellent'' or ''good'' outcomes were reported for first rib resection for neurogenic TOS. As an example, Urschel and Razzuk 8 reported ''excellent'' results in more than 95% of 2200 transaxillary first rib resections for neurogenic TOS.
It has only been within approximately the last 2 decades that investigators of neurogenic TOS have begun to evaluate surgical outcomes with semiquantitative patient questionnaires of pain and functional disability, including the Disabilities of the Arm, Shoulder and Hand questionnaire, the Cervical-Brachial Symptom Questionnaire, and the ShortForm 12, among other validated instruments. With these tools, investigators have demonstrated that both physical and mental quality of life improve immediately after surgical decompression for TOS 9 and that such quality of life gains are sustained for relatively long periods. 10 Whereas these self-assessment metrics are regarded as an improvement from the use of clinical assessment scales, they are also limited by incomplete assessment of surgical outcomes: these questionnaires are highly subjective, variable, and subject to the biases inherent in survey sampling. For example, surgical outcomes may influence a subject's willingness to participate and thus lead to selection bias.
Reporting of objective outcome measures in neurogenic TOS is extremely rare. In a recent report, Thompson and colleagues 11 studied objective performance outcomes in 10 Major League Baseball pitchers with neurogenic TOS who returned to Major League Baseball after first rib resection and physical therapy. 11 In this study, Thompson and colleagues 11 compared highly granular career pitching measurements, including 15 traditional pitching metrics (including earned run average, walks plus hits per inning pitched, and strikeout/walk ratio) and 72 advanced pithing metrics with PitchF/x data (including pitch velocity, spin rate, and spin direction) before and after neurogenic TOS treatment. On the pitchers' return to Major League Baseball, 75% of these metrics were unchanged, 19% were significantly improved, and only 6% were significantly decreased. This study showcases how innovative approaches with objective performance metrics can define the success of an approach to neurogenic TOS treatment with high confidence. To apply similar concepts to nonathlete patients with neurogenic TOS, one can envision the use of wearable sensors and machine-learning algorithms for evaluation and comparison of preoperative and postoperative upper extremity function as an objective means of assessing response to TOS surgery.
MITIGATION OF RISK BYA MULTIDISCIPLINARY PROGRAM
Injury precedes neurogenic TOS in approximately 50% of cases, and some patients may be concurrently seeking economic or legal redress for their injuries. 12 Notably, these pursuits may interfere with the accuracy of symptom selfreporting. The prevalence of malpractice litigation in neurogenic TOS practice is information that is not readily available to the public; however, neurogenic TOS is often discussed as a surgical discipline associated with substantial legal risk. A review of malpractice lawyer group websites specializing in TOS cases has revealed 2 prominent themes: insufficient nonoperative therapy before surgery and inadequate informed consent, remarked in statements such as, ''If your surgeon operated too early or failed to inform you of the risks of surgery and alternatives to surgery, then a lawsuit may be appropriate.'' In his 1982 presidential address to The American Association for Thoracic Surgery, ''The Crisis of Excellence,'' Dr Thomas B. Ferguson addressed the issue of malpractice in the field of thoracic surgery. 13 Through access to the National Association of Insurance Commissioners database, Dr Ferguson evaluated malpractice claims involving thoracic surgery between 1975 and 1978 and demonstrated that the greatest frequency of suits (21%) occurred after transaxillary first rib resection. Surgical complications were the reasons for these claims, and the most common complication was nerve injury, presumably including brachial plexus injury.
The true incidence of complications from first rib resection, such as brachial plexus injury, is difficult to discern. An anonymous national survey published in 1982 demonstrated that 52% of the 259 participating surgeons performing transaxillary first rib resection observed brachial plexus injury resulting in complete postoperative paralysis in 102 instances (33 from personal cases and 69 observed among colleagues) and resulting in partial neurologic deficit in 171 instances (60 personal cases and 111 observed cases).
14 In contrast, in published large, singleinstitution series of first rib resection, the rate of brachial plexus injury from first rib resection ranges 0% 2, 6, [15] [16] [17] to 0.08% 18 to 1.1%. 19 Similarly, a multi-institution administrative database study evaluating 2016 first rib resections for neurogenic TOS reported that brachial plexus injury occurs in 0.6% of first rib resections. 20 In a relatively smaller single-institution series of 102 first rib resections, however, brachial plexus injury was reported in 9% of first rib resections performed through the transaxillary approach and 4% of first rib resections performed through the supraclavicular approach. 21 Additional technical complications resultant from first rib resection include phrenic nerve injury, long thoracic nerve injury, and injury to the subclavian vessels. Taken together, it is reasonable to conclude that publication biases limit our understanding of the true incidence of complications after first rib resection.
Multidisciplinary team approaches have been conclusively shown to improve quality of life and long-term outcomes in patients with a variety of cancers, including those treated surgically (a representation is given in reference 22 ). At my institution (Baylor College of Medicine, Houston, Tex), we believe that the same principles can be applied to patients with neurogenic TOS, and that a structured multidisciplinary strategy for neurogenic TOS (Figure 1 ) will (1) mitigate legal risk and (2) improve patient outcomes. The proposed benefits of such a program include increase in diagnostic accuracy for neurogenic TOS and for competing diagnoses, decrease in time to definitive treatment, establishment of clinical protocols to streamline and standardize care (Figure 2 ), and assurance of appropriate ''standard-ofcare'' treatment algorithms. Integrated into this program are mechanisms to guarantee and document comprehensive informed consent before any surgical procedure ( Figure E1) . A model that we have found particularly useful is one that includes the thoracic surgeon and a physical medicine and rehabilitation physician in leadership roles. In this system, every new patient with suspected neurogenic TOS is evaluated by both these physicians on their initial visit, and all new and established cases are reviewed weekly by these 2 core team members. The physical medicine and rehabilitation component of this program has proved indispensable for refinement of diagnosis, for arrangement and evaluation of response to physical therapy, and for management of chronic pain and disability. Other critical members of the team include a vascular or endovascular surgeon for collaboration on venous and arterial TOS cases, a spine surgeon for evaluation of cervical radiculopathy when appropriate, and shoulder and extremity surgeons for cases including possible shoulder pathology, ulnar nerve entrapment, and carpal tunnel syndrome. Further, because symptoms of neurogenic TOS may be associated with complex psychologic problems, including somatoform disorders, 23 recruitment of a psychiatrist to the program may have substantial value.
TECHNIQUE
Thoracic outlet syndrome is a condition that is treated surgically by a variety of surgical subspecialties including thoracic surgery, vascular surgery, orthopedic surgery, neurosurgery, and plastic surgery. Among the 1431 first/cervical rib resection sample from the American College of Surgeons National Surgical Quality Improvement Program database, it was determined that 90% of procedures were performed by vascular surgeons (3), however, thoracic surgeons are uniquely positioned to care for patients with thoracic outlet syndrome.
Resection of the first rib with either scalenectomy or scalenotomy is procedure required to decompress the thoracic outlet in neurogenic TOS. It is often discussed that complete resection of the posterior first rib (to the level of the transverse process) is necessary to achieve favorable surgical outcome in neurogenic TOS. On the basis of the anatomy of the thoracic outlet and studies that correlate a long stump of residual rib after rib resection with early recurrence of neurogenic TOS, 24 this is a rationally grounded principle. The most common approaches to first rib resection are supraclavicular and transaxillary. Large published experiences with each approach have demonstrated good outcomes, and the superiority of one approach to the other has not been definitively demonstrated. Both approaches, however, share common disadvantages. Shortcomings of both the supraclavicular and transaxillary approaches include limited exposure and visualization of the first rib and a requirement for manipulation or retraction of the brachial plexus, the latter of which may be more pronounced during supraclavicular first rib resection. Moreover, these disadvantages are amplified in patients with overweight body habitus during each of these approaches. Exposure of the right first rib through the supraclavicular approach is illustrated in Figure 3 , A, and limited exposure of the first rib is also present in the transaxillary approach.
Transthoracic approaches to first rib resection have been reported and include thoracoscopic transthoracic first rib resection 25 and thoracoscopically assisted transaxillary first rib resection. 26 Robotically assisted thoracoscopic first rib resection has also been described. 27, 28 A minimally invasive (robotic or thoracoscopic) transthoracic approach to first rib resection has clear advantages relative to traditional approaches, namely (1) unrivaled visualization of the entire (anterior and posterior) first rib (Figure 3, B) , (2) no manipulation (retraction or stretching) of the brachial plexus or subclavian vessels, and (3) independence from body habitus in attaining consistent outstanding exposure. These attributes of this approach, taken together with sustained visualization of the brachial plexus, subclavian artery, subclavian vein, and phrenic nerve, can be rationally predicted to mitigate complications from first rib resection. An additional advantage of the unprecedented and videoprojected exposure afforded by a transthoracic minimally invasive approach is facilitation of the teaching of residents, fellows, and all members of the operating room team. A video of my technique of robotically assisted thoracoscopic first rib resection for neurogenic TOS (and also for venous TOS) accompanies this article (Video 1).
CONCLUSIONS
Many of the controversies that surround neurogenic TOS are opportunities for innovation. The great majority of TOS cases are neurogenic, and thoracic surgeons are uniquely equipped to care for these patients. The minimally invasive transthoracic approach to first rib resection provides unrivaled exposure to the first rib, regardless of patient build, without need for manipulation of the brachial plexus or subclavian vessels, and it is expected to minimize operative risk.
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